|
You are here: Home: BCU Surgeons Vol.2 Issue 4: Faculty
disclosures
FACULTY DISCLOSURES
As a provider accredited by the ACCME, it
is the policy of NL Communications Inc to require the disclosure
of any significant financial interest or any other relationship
the sponsor or faculty members have with the manufacturer(s)
of any commercial product(s) discussed in an educational presentation.
The presenting faculty reported the following:
| William
C Wood, MD |
Honorarium: Aventis Pharmaceuticals
Inc |
| Norman
Wolmark, MD |
No financial interests or affiliations to disclose |
| Aman
Buzdar, MD, FACP |
Grants/Research Support: AstraZeneca Pharmaceuticals LP, Eli Lilly & Company, Pfizer
Inc, Genentech Inc, Bristol-Myers Squibb Company, Roche Laboratories
Inc |
| David
N Krag, MD, FACS |
No financial interests or affiliations to disclose |
| Charles Loprinzi, MD |
No financial interests or affiliations
to disclose |
| Pharmaceutical
agents discussed in this program |
| G
E N E R I C |
T
R A D E |
M
A N U F A C T U R E R |
| anastrozole |
Arimidex® |
AstraZeneca Pharmaceuticals
LP |
| capecitabine |
Xeloda® |
Roche Laboratories Inc |
| carboplatin |
Paraplatin® |
Bristol-Myers Squibb
Company |
| citalopram HBr |
Celexa® |
Forest Pharmaceuticals
Inc |
| clodronate |
Various |
Various |
| clonidine |
Catapres® |
Boehringer Ingelheim |
| docetaxel |
Taxotere® |
Aventis Pharmaceuticals
Inc |
| exemestane |
Aromasin® |
Pfizer Inc |
| fluoxetine HCL |
Prozac® |
Eli Lilly & Company |
| gabapentin |
Neurontin® |
Pfizer Inc |
| goserelin |
Zoladex® |
AstraZeneca Pharmaceuticals
LP |
| letrozole |
Femara® |
Novartis Pharmaceuticals
Corporation |
| medroxyprogesterone acetate |
Various |
Various |
| megestrol acetate |
Megace® |
Bristol-Myers Squibb
Company |
| pamidronate |
Aredia® |
Novartis Pharmaceuticals
Corporation |
| paroxetine HCI |
Paxil® |
GlaxoSmithKline |
| raloxifene |
Evista® |
Eli Lilly & Company |
| tamoxifen citrate |
Nolvadex® |
AstraZeneca Pharmaceuticals
LP |
| triptorelin |
Various |
Various |
| venlafaxine HCI |
Effexor® XR |
Wyeth Pharmaceuticals
Inc |
| vinorelbine |
Navelbine® |
GlaxoSmithKline |
| zoledronic acid/zoledronate |
Zometa® |
Novartis Pharmaceuticals
Corporation |
This educational activity contains discussion of published and/or
investigational uses of agents that are not indicated by the
Food and Drug Administration. NL Communications Inc does not
recommend the use of any agent outside of the labeled indications.
Please refer to the official prescribing information for each
product for discussion of approved indications, contraindications
and warnings. The opinions expressed are those of the presenters
and are not to be construed as those of the publisher or grantor.
|
|
|
